Welireg (belzutifan) - Merck (MSD)
Welireg: Newly added patents in Orange Book (Orange Book) - May 30, 2025 - Expiry on Sep 5, 2034 
Patent Genetic Disorders • Genito-urinary Cancer • Kidney Cancer • Neuroendocrine Tumor • Oncology • Renal Cell Carcinoma • Solid Tumor • Von Hippel-Lindau Syndrome
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
 
May 30, 2025
 
 
04700e8b-be43-4d36-99ee-f47b4a596ea9.png